3 ms·
pretty biased article. Didn't cite the many doctors who are using it in their treatment regimen, Japan Medical Association board member endorsement, or the pop
by jpadkins 5y ago
pretty biased article. Didn't cite the many doctors who are using it in their treatment regimen, Japan Medical Association board member endorsement, or the population studies in India and Africa that show pretty compelling evidence. Also they didn't cover the early treatment vs. late stage when discussing the study results (ivermectin doesn't help people with high viral load already in the ICU, but apparently does help people who just got the virus).
[edited to correct JMA board member, not health minister]
- skuhn 5y agoThe person in Japan who endorsed ivermectin is not a government minister. [1] If you're referring to the Elgazzar paper from Egypt (as the "population studies in [..] Africa"), then it has been withdrawn from pre-print distribution. [2] And, in general, the studies that have been performed are not sufficient to support ivermectin use among the general public at this time. [3] [1] https://factcheck.afp.com/http%253A%252F%252Fdoc.afp.com%252F9M48JR-1 https://factcheck.afp.com/http%253A%252F%252Fdoc.afp.com%252... [2] https://www.theguardian.com/science/2021/jul/16/huge-study-supporting-ivermectin-as-covid-treatment-withdrawn-over-ethical-concerns https://www.theguardian.com/science/2021/jul/16/huge-study-s... [3] https://www.the-scientist.com/news-opinion/ivermectin-still-lacks-scientific-support-as-a-covid-19-drug-69049 https://www.the-scientist.com/news-opinion/ivermectin-still-...
- jpadkins 5y agoThank you for the thoughtful reply. Ozaki is on the JMA Board https://www.med.or.jp/english/about_JMA/trustees.html https://www.med.or.jp/english/about_JMA/trustees.html The population study I was referring to was this one: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1657-95342020000400201 http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S... citation 3 is an opinion piece (opinion section of that magazine). And even as a persuasion piece, it still quotes Cochrane on the need for a serious study.
- kazinator 5y agoThe National Geographic article has a point of view. This is evident from its very title "[t]he shaky science behind ivermectin as a COVID-19 cure"; we may expect the content of the article to be biased toward making the case that the hypothesis is shaky. I posted it not because I care about its point of view, but because it was one of the first items I was able to find quickly which provides a synopsis of what I was looking for: the origins of the ivermectin hypotheses in respect to COVID.